The Suppressive effects of Lanthanum on the production of inflammatory mediators in mice challenged by LPS

Biological Trace Element Research

Volumn 142, Issue 3, 2011, Pages 693-703

  Guo, Fei ^a   Guo, Xiang ^b   Xie, An ^a   Lou, Yuan Lei ^a   Wang, Yang ^a  

^a NANCHANG UNIVERSITY   (China)

^b Jiu Jiang University   (China)

Author keywords

Lanthanum; Lipopolysaccharide; Nuclear factor kappaB; Tumornecrosis factor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LANTHANUM CHLORIDE; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; FEMALE; GENE EXPRESSION REGULATION; IN VITRO STUDY; IN VIVO STUDY; MEDIATOR RELEASE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; SURVIVAL RATE; UPREGULATION;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; FEMALE; LANTHANUM; LIPOPOLYSACCHARIDES; LIVER; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED BALB C; POLYMERASE CHAIN REACTION; RADIOIMMUNOASSAY; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 80051794025     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-010-8792-0     Document Type: Article

References (14)

1. Pinsky MR (2007) Sepsis and multiple organ failure. Contrib Nephrol 156:47-63
2. Shigematsu T (2008) Lanthanum carbonate effectively controls serum phosphate without affecting serum calcium levels in patients undergoing hemodialysis. Ther Apher Dial 12:55-61 (Pubitemid 351197453)
3. Hutchison AJ, Barnett ME, Krause R et al (2009) Lanthanum carbonate treatment, for up to 6 years, is not associated with adverse effects on the liver in patients with chronic kidney disease stage 5 receiving hemodialysis. Clin Nephrol 71:286-295
4. Hadjiiski OG, Lesseva MI (1999) Comparison of four drugs for local treatment of burn wounds. Eur J Emerg Med 6:41-47
5. de Gracia CG (2001) An open study comparing topical silver sulfadiazine and topical silver sulfadiazinecerium nitrate in the treatment of moderate and severe burns. Burns 27:67-74 (Pubitemid 32054743)
6. Roland CR, Naziruddin B, Mohanakumar T et al (1996) Gadolinium chloride inhibits Kupffer cell nitric oxide synthase (iNOS) induction. J Leukoc Biol 60:487-492 (Pubitemid 26356774)
7. Fujii Y, Goldberg P, Hussain SN (1998) Contribution of macrophages to pulmonary nitric oxide production in septic shock. Am J Respir Crit Care Med 157:1645-1651
8. Reed LJ, Munch H (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27:493-497
9. Yao YM, Xu CL, Yao FH et al (2006) The pattern of nuclear factor-kappaB activation in rats with endotoxin shock and its role in biopterin-mediated nitric oxide induction. Zhonghua Shao Shang Za Zhi 22:405-410
10. Denlinger LC, Garis KA, Sommer JA et al (1998) Nuclear translocation of NF-kappaB in lipopolysaccharide-treated macrophages fails to correspond to endotoxicity: evidence suggesting a requirement for a gamma interferon-like signal. Infect Immun 66:1638-1647 (Pubitemid 128471529)
11. Zhang P, Martin M, Michalek S et al (2005) Role of mitogen-activated protein kinases and NF-κB in the regulation of proinflammatory and anti-inflammatory cytokines by porphyromonas gingivalis hemagglutinin B. Infect Immun 73:3990-3998 (Pubitemid 40923138)
12. Cogswell JP, Godlevski MM,Wisely GB et al (1994) NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a nonconsensus CRE-like site. J Immunol 153:712-723
13. Parmentier M, Hirani N, Rahman I et al (2000) Regulation of lipopolysaccharide-mediated interleukin- 1beta release by N-acetylcysteine in THP-1 cells. Eur Respir J 16:933-939 (Pubitemid 32049382)
14. Li Q, Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2:725-734